Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
INTRODUCTION: Breast cancer is a common disease with distinct tumor subtypes phenotypically characterized by ER and HER2/neu receptor status. MiRNAs play regulatory roles in tumor initiation and progression, and altered miRNA expression has been demonstrated in a variety of cancer states presenting...
Main Authors: | Ailbhe M McDermott, Nicola Miller, Deirdre Wall, Lorcan M Martyn, Graham Ball, Karl J Sweeney, Michael J Kerin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3909065?pdf=render |
Similar Items
-
Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
by: Ailbhe M McDermott, et al.
Published: (2013-01-01) -
Relationship between circulating and tissue microRNAs in a murine model of breast cancer.
by: Peadar S Waters, et al.
Published: (2012-01-01) -
Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
by: Yuliya A. Veryaskina, et al.
Published: (2020-05-01) -
Impact of cellular miRNAs on circulating miRNA biomarker signatures.
by: Radha Duttagupta, et al.
Published: (2011-01-01) -
Luminal DMSO: Effects on Detrusor and Urothelial/Lamina Propria Function
by: Katrina J. Smith, et al.
Published: (2014-01-01)